ARS Pharmaceuticals (SPRY) Depreciation and Depletion (2020 - 2024)
ARS Pharmaceuticals' (SPRY) quarterly Depreciation and Depletion came in at $29000.0 in Q4 2024, up 141.67% year-on-year from $12000.0 in Q1 2024, and up 38.1% quarter-over-quarter from $21000.0 in Q3 2024.
ARS Pharmaceuticals (SPRY) Depreciation and Depletion (2020 - 2024) Analysis & Trends
ARS Pharmaceuticals has disclosed Depreciation and Depletion across 5 years of filings, most recently posting $29000.0 for Q4 2024.
- Depreciation and Depletion for Q4 2024 came in at $29000.0, up 141.67% year-over-year; the trailing twelve-month figure through Dec 2024 was $79000.0 (up 8.22% YoY), and the FY2024 annual result was $79000.0, up 8.22% from the prior year.
- Depreciation and Depletion came in at $29000.0 for Q4 2024 at ARS Pharmaceuticals, up from $21000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $209000.0 in Q2 2021 to a low of -$37000.0 in Q2 2022.
- The 5-year median for Depreciation and Depletion is $25000.0 (2023), against an average of $79300.0.
- Across the five-year window, Depreciation and Depletion sank 117.7% in 2022 and surged 200.0% in 2023, its largest moves.
- ARS Pharmaceuticals' Depreciation and Depletion stood at $152000.0 in 2020, then jumped by 34.21% to $204000.0 in 2021, then slumped by 93.14% to $14000.0 in 2022, then fell by 14.29% to $12000.0 in 2023, then surged by 141.67% to $29000.0 in 2024.
- The last three Depreciation and Depletion figures came in at $29000.0 (Q4 2024), $21000.0 (Q3 2024), and $18000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | ARS Pharmaceuticals | 954.24 Mn | 753.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 29,000.00 |
| Dec 31, 2024 | 29,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |